+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Maternal antibodies protect immunoglobulin deficient neonatal mice from mouse hepatitis virus (MHV)-associated wasting syndrome

American Journal of Reproductive Immunology 36(1): 33-39

Maternal antibodies protect immunoglobulin deficient neonatal mice from mouse hepatitis virus (MHV)-associated wasting syndrome

Neonatal mice nursed by dams lacking immunoglobulins (Igs) may often suffer from lethal runting if raised under conventional conditions. The present study was performed in order to clarify a) the cause of the wasting syndrome and b) the protective role of antigen-specific milk antibodies. Ig-deficient mouse embryos in a conventional environment were embryo-transferred to specified pathogen free (SPF) dams. Neonatal growth, mortality, and health status of mice from both environments was recorded. Suspected presence of mouse hepatitis virus (MHV) was tested by RT-PCR. Protective effects on neonatal mortality of milk containing different titers of anti-MHV antibodies were investigated in cross-fostering experiments. The SPF colony of Ig-deficient mice exhibited no breeding problems, whereas Ig-deficient neonates in the conventional environment suffered from lethal wasting syndrome. Serological screening of the mice kept in the two environments revealed that mice in the conventional room had high titers of antibodies against mouse hepatitis virus. Presence of MHV in runting neonates was confirmed by pathological examinations and RT-nested-PCR using MHV genome specific primers. Milk containing high titers of anti-MHV antibodies, when provided for 8 days or more, completely prevented Ig-deficient neonates from developing wasting syndrome in the conventional environment. These findings show that the neonatal wasting syndrome is associated with the presence of MHV and that neonates are efficiently protected by MHV-specific antibodies in the milk.

Accession: 002891312

PMID: 8831899

DOI: 10.1111/j.1600-0897.1996.tb00136.x

Download PDF Full Text: Maternal antibodies protect immunoglobulin deficient neonatal mice from mouse hepatitis virus (MHV)-associated wasting syndrome

Related references

Isolation of low-virulent mouse hepatitis virus from nude mice with wasting syndrome and hepatitis. Japanese Journal of Experimental Medicine 45(5): 429-432, 1975

Monoclonal antibodies to the matrix (E1) glycoprotein of mouse hepatitis virus protect mice from encephalitis. Virology 168(1): 162-167, 1989

Immunoglobulin G monoclonal antibodies to Cryptococcus neoformans protect mice deficient in complement component C3. Infection and Immunity 70(5): 2598-2604, 2002

Hepatitis and brain lesions due to mouse hepatitis virus accompanied by wasting in nude mice. Laboratory Animals 8(3): 317-326, 1974

Response of nude mice to a mouse hepatitis virus isolated from a wasting nude mouse. Japanese Journal of Experimental Medicine 46(1): 19-30, 1976

Immunoglobulin-A antibodies in upper airway secretions may inhibit intranasal influenza virus replication in mice but not protect against clinical illness. Scandinavian Journal of Immunology 61(6): 503-510, 2005

T cell development in b cell deficient mice 2. serological characterization of suppressor t cell factors tsf 1 produced in normal mice and in mice treated chronically with rabbit anti mouse immunoglobulin m antibodies. Journal of Experimental Medicine 161(6): 1402-1413, 1985

Neutralizing antibodies induced by cell culture-derived hepatitis C virus protect against infection in mice. Gastroenterology 145(2): 447-55.E1-4, 2013

Simultaneous detection of immunoglobulin m antibodies to hepatitis a virus immunoglobulin m anti hepatitis a virus and immunoglobulin m antibodies to viral capsid antigen of epstein barr virus immunoglobulin m anti viral capsid antigen epstein barr virus in patients with acute viral hepatitis. Gastroenterologie Clinique et Biologique 9(2): 109-112, 1985

Vertical transmission of hepatitis b virus and prevention of chronic neonatal hepatitis b virus infection by a combination of human antihepatitis b immunoglobulin and hepatitis b vaccine. Boei Ika Daigakko Zasshi 9(1): 50-59, 1984